text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Mosapride Citrate

text: vAbl-ProB

characteristic: well


status: PUBLIC

characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

tag: attribute

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

characteristic: organism

text: Gatifloxacin

characteristic: sample type

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Letrozole

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Exemestane

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Granisetron HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Adapalene

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Lansoprazole

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Daptomycin

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Levetiracetam

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Angiotensin II

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cycling

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Gentamycin Sulfate

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Geneticin, G-418 Sulfate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Chloramphenicol

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Carbenicillin, Disodium Salt

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ampicillin

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Leucovorin Calcium

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Malotilate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Idarubicin HCl

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pamidronate Disodium

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Epirubicin HCl

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Fluoxetine HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Acarbose

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Acitretin

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Floxuridine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Mercaptopurine (6-MP)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Cyclophosphamide

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Dexamethasone (DHAP)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ellagic acid

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tivozanib (AV-951)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Genistein

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Dacarbazine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cycling

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cladribine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Lenvatinib (E7080)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Carboplatin

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Dovitinib (TKI-258, CHIR-258)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Bosutinib (SKI-606)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Saracatinib (AZD0530)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ifosfamide

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Doripenem Hydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Plerixafor (AMD3100)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Bendamustine HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Etoposide

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Etomidate

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: MEK162 (ARRY-162, ARRY-438162)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Carfilzomib (PR-171)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: (-)-Huperzine A

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Macitentan

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Decitabine (NSC127716, 5AZA-CdR)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: E 64d

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Cediranib (AZD217)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Bumetanide

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pelitinib (EKB-569)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Doxorubicin (Adriamycin) HCl

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Imatinib Mesylate (STI571)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Mianserin HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Vatalanib (PTK787) 2HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Entecavir Hydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Vincristine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Tenofovir Disoproxil Fumarate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Ramelteon

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Galanthamine HBr

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: DMSO

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Roscovitine (Seliciclib,CYC202)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: IPI-145 (INK1197)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Posaconazole

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Aprepitant

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Enzastaurin (LY317615)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Celecoxib

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Dutasteride

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Dimesna

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Epothilone B (EPO906, Patupilone)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Prasugrel

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Dexrazoxane HCl (ICRF-187, ADR-529)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Lidocaine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cilnidipine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: CP-945598 HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Fulvestrant

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Losartan Potassium (DuP 753)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Clofarabine

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rigosertib (ON-01910,Estybon)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Gemcitabine HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Nelarabine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Biapenem

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rocuronium Bromide

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: DMSO

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Zoledronic Acid

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Mosapride Citrate

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Gatifloxacin

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Letrozole

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Exemestane

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Granisetron HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Adapalene

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Lansoprazole

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Daptomycin

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Levetiracetam

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Angiotensin II

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cycling

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pyrimethamine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Anagrelide HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pralatrexate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: S- (+)-Rolipram

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Trilostane

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Methotrexate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Aminophylline

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ozagrel

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Dyphylline

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Gimeracil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Apixaban

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pimobendan

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rivaroxaban

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cilostazol

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Mycophenolate Mofetil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Avanafil

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Isotretinoin

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cilomilast

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rolipram

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tadalafil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: TAK-700 (Orteronel)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pioglitazone HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cycling

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Vardenafil HCl Trihydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Clarithromycin

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Sildenafil Citrate

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Voriconazole

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Roflumilast

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Apremilast (CC-10004)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ketoconazole

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cobicistat (GS-9350)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rosiglitazone HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Ciprofibrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Rosiglitazone

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rosiglitazone maleate

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Abiraterone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Amuvatinib (MP-470, HPK 56)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Methylprednisolone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cyclophosphamide monohydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tipifarnib (Zarnestra)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Birinapant (TL32711)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Thalidomide

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pomalidomide (CC-4047)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Lenalidomide (CC-5013)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: 2-Methoxyestradiol (2-MeOE2)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: FG-4592 (ASP1517)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Resveratrol

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: EX 527 (SEN0014196)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Thioguanine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Entacapone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Iniparib (BSI-201)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rucaparib (AG-014699,PF-01367338)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Olaparib (AZD2281, Ku-0059436)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: BMN 673

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: DMSO

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Baricitinib (LY3009104, INCB028050)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tofacitinib (CP-690550,Tasocitinib)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: TG101348 (SAR302503)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Tofacitinib (CP-690550) Citrate

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Barasertib (AZD1152-HQPA)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: VX-680 (MK-0457,Tozasertib)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: MLN8237 (Alisertib)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Sodium Phenylbutyrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Valproic acid sodium salt (Sodium valproate)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: PCI-24781 (CRA-024781)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Belinostat (PXD101)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Pracinostat (SB939)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Mocetinostat (MGCD0103, MG0103)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Vorinostat (SAHA, MK0683)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rocilinostat (ACY-1215)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Olmesartan medoxomil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Moxonidine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Captopril

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Raltegravir (MK-0518)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Empty

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Fluorouracil (Adrucil)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Elvitegravir (GS-9137)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: 17-AAG (KOS953)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Doxycycline hyclate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: GM 6001

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Marimastat

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Atazanavir sulfate (BMS-232632-05)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Alogliptin (SYR-322)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Vildagliptin (LAF-237)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Sitagliptin phosphate monohydrate

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cycling

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pyrimethamine

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Anagrelide HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pralatrexate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: S- (+)-Rolipram

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Trilostane

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Methotrexate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Aminophylline

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Ozagrel

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Dyphylline

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Gimeracil

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Apixaban

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pimobendan

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rivaroxaban

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cilostazol

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Mycophenolate Mofetil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Avanafil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Isotretinoin

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cilomilast

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rolipram

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tadalafil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: TAK-700 (Orteronel)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pioglitazone HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cycling

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Vardenafil HCl Trihydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Clarithromycin

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Sildenafil Citrate

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Voriconazole

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Roflumilast

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Apremilast (CC-10004)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ketoconazole

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cobicistat (GS-9350)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rosiglitazone HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ciprofibrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Rosiglitazone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rosiglitazone maleate

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Abiraterone

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Amuvatinib (MP-470, HPK 56)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Methylprednisolone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cyclophosphamide monohydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tipifarnib (Zarnestra)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Birinapant (TL32711)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Thalidomide

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Pomalidomide (CC-4047)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Lenalidomide (CC-5013)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: 2-Methoxyestradiol (2-MeOE2)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: FG-4592 (ASP1517)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Resveratrol

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: EX 527 (SEN0014196)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Thioguanine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Entacapone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Iniparib (BSI-201)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Rucaparib (AG-014699,PF-01367338)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Olaparib (AZD2281, Ku-0059436)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: BMN 673

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: DMSO

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Baricitinib (LY3009104, INCB028050)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tofacitinib (CP-690550,Tasocitinib)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: TG101348 (SAR302503)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Tofacitinib (CP-690550) Citrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Barasertib (AZD1152-HQPA)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: VX-680 (MK-0457,Tozasertib)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: MLN8237 (Alisertib)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Sodium Phenylbutyrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: PCI-24781 (CRA-024781)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Belinostat (PXD101)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pracinostat (SB939)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Mocetinostat (MGCD0103, MG0103)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Vorinostat (SAHA, MK0683)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rocilinostat (ACY-1215)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Olmesartan medoxomil

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Moxonidine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Captopril

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Raltegravir (MK-0518)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Empty

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Fluorouracil (Adrucil)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Elvitegravir (GS-9137)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: 17-AAG (KOS953)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Doxycycline hyclate

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: GM 6001

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Marimastat

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Atazanavir sulfate (BMS-232632-05)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Alogliptin (SYR-322)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Vildagliptin (LAF-237)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Sitagliptin phosphate monohydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Cycling

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pyrimethamine

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Anagrelide HCl

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pralatrexate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: S- (+)-Rolipram

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Trilostane

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Methotrexate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Aminophylline

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Ozagrel

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Dyphylline

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Gimeracil

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Apixaban

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pimobendan

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rivaroxaban

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cilostazol

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Mycophenolate Mofetil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Avanafil

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Isotretinoin

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Cilomilast

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rolipram

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tadalafil

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: TAK-700 (Orteronel)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pioglitazone HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cycling

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Vardenafil HCl Trihydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Clarithromycin

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Sildenafil Citrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Voriconazole

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Roflumilast

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Apremilast (CC-10004)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ketoconazole

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cobicistat (GS-9350)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rosiglitazone HCl

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Ciprofibrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Rosiglitazone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Rosiglitazone maleate

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Abiraterone

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Amuvatinib (MP-470, HPK 56)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Methylprednisolone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Cyclophosphamide monohydrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tipifarnib (Zarnestra)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Birinapant (TL32711)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Thalidomide

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Pomalidomide (CC-4047)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Lenalidomide (CC-5013)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: 2-Methoxyestradiol (2-MeOE2)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: FG-4592 (ASP1517)

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Resveratrol

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: EX 527 (SEN0014196)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Thioguanine

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Entacapone

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Iniparib (BSI-201)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Rucaparib (AG-014699,PF-01367338)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Olaparib (AZD2281, Ku-0059436)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: BMN 673

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: DMSO

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Baricitinib (LY3009104, INCB028050)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tofacitinib (CP-690550,Tasocitinib)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: TG101348 (SAR302503)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Tofacitinib (CP-690550) Citrate

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Barasertib (AZD1152-HQPA)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: VX-680 (MK-0457,Tozasertib)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: MLN8237 (Alisertib)

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Sodium Phenylbutyrate

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: PCI-24781 (CRA-024781)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Belinostat (PXD101)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Pracinostat (SB939)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Mocetinostat (MGCD0103, MG0103)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Vorinostat (SAHA, MK0683)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: Rocilinostat (ACY-1215)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Olmesartan medoxomil

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Moxonidine

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Captopril

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Raltegravir (MK-0518)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission model

characteristic: SRA accession

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Empty

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: bait

text: vAbl-ProB

characteristic: cell line

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Fluorouracil (Adrucil)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

characteristic: cell type

text: missing

text: WT

characteristic: genotype

text: missing

text: Mus musculus

text: Elvitegravir (GS-9137)

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

characteristic: organism

text: 17-AAG (KOS953)

characteristic: sample type

text: vAbl-ProB


text: Radiation Oncology, Stanford University

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Doxycycline hyclate

text: vAbl-ProB

characteristic: title

characteristic: treatment


text: Radiation Oncology, Stanford University

text: live

text: Generic

characteristic: NCBI submission package

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: GM 6001

text: vAbl-ProB

characteristic: well


characteristic: External Id

text: Radiation Oncology, Stanford University

characteristic: INSDC center name

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Marimastat

text: vAbl-ProB


text: Radiation Oncology, Stanford University

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Generic

text: vAbl-ProB

text: pro-B cells

text: missing

text: WT

text: missing

text: Mus musculus

text: Atazanavir sulfate (BMS-232632-05)

text: vAbl-ProB